Photo Credits: Pixabay
Lyfas Mobile App: The trend of rapid increase in the cases of Coronavirus Outbreak In India continues. However, all efforts are being made to stop the spread of this infection. Meanwhile, a startup based in Bengaluru (Bengaluru) has developed a mobile app that will help in easily detecting the infected with COVID-19. Kovid-19 has designed this mobile application to detect infected people and assess risk. The mobile app uses the power of smartphone processors and smartphone sensors to capture body signals. The Department of Science and Technology (DST) in association with CAWACH selected Acculi Labs of Bengaluru to create the Lyfas COVID score to evaluate the COVID-19 risk.
Lyfas is a clinical grade, non-invasive, digital functional biomarker smartphone tool developed by Acculi Labs. Which will help in screening, early detection, root cause analysis, rapid incidence risk assessment, prognosis and monitoring of chronic illnesses at home. Clinical trial and regulatory proceedings are expected to be completed by the end of September, after which the testing facility will be provided to the general public.
Lyfas’ App works like this
- Lyfas is an Android application, which requires placing the index finger on the rear phone camera of the mobile phone for about 5 minutes.
- This app captures changes in capillary pulse and blood volume, then achieves 95 biomarkers with proprietary algorithms and signal processing techniques.
- This app uses the power of smartphone processors and smartphone sensors to capture a set of body signals.
- The signals are subsequently modified on the principle of Photoplethysmography (PPG), Photo Chromatography (Photo Chromatography (PCG), Arterial (Photoplethysmography (APPG), Mobile spirometry (mobile spirometry) and Pulse Rate Variability (PRV)). .
- Lyfas then provides cardio-respiratory, cardio-vascular, hematology, haemology, neurology based parameters, which are capable of tracking minute pathophysiological changes in the body. These changes can be made about organ system-wide responses. Also read: Vertical COVID-19 Transmission: First case of vertical Kovid-19 transmission from mother to baby in the country came to light, the girl was discharged from Pune hospital after treatment
According to a government release, the new technology has been developed with the support of DST. That an anomalous person will detect a possible infection. This will help prioritize traditional test queues and help in evaluating risk assessment.
This technique focuses on population screening, surveillance of persons living in quarantine and monitoring in the community dissemination phase. In a study conducted with Medanta Medicity Hospital, with an accuracy of 92 percent, specificity of 90 percent and sensitivity of 92 percent, Lyfas Mobile App has been found to be effective in detecting Kovid-19 patients.